Azithromycin for Meningococcal Carriage

Launched by EMORY UNIVERSITY · Sep 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of a medication called azithromycin to see if it can help eliminate the bacteria that cause meningococcal infections from the throat and nose area. Meningococcal infections can lead to serious health problems, so finding effective treatments is important. The trial is currently looking for participants who are undergraduate or graduate students living in university-affiliated housing or off-campus housing at Emory University.

To be eligible for the study, participants need to be between the ages of 18 and 30, and they must be able to understand the study and give their consent to participate. Unfortunately, people who are pregnant or breastfeeding, have had allergic reactions to azithromycin, or have taken antibiotics in the last month cannot join the study. If you choose to participate, you will be involved in a process that helps researchers learn more about how well azithromycin works against this specific type of bacteria, which could ultimately improve treatment options for meningococcal infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Able to provide their own informed consent and understand study procedures
• • Undergraduate and graduate students attending Emory University affiliated campuses who reside in university affiliated housing (for undergraduate/graduate) or in off-campus housing (undergraduates).
• Exclusion Criteria:
• • University faculty and staff
• • Currently pregnant or breast feeding
• • History of immediate or moderate-to-severe allergic reactions to azithromycin
• • Individuals who have taken systemic antibiotics for any reason in the 30 days prior to enrollment
• • Individuals with any symptoms of acute illness at the time of screening